Kezar Life Sciences Inc (KZR) - News Archive

: Kezar Life Sciences, a clinical-stage biotechnology company, is poised to present significant data from its Phase 2a PORTOLA clinical trial evaluating the efficacy of zotomipzomib in treating autoimmune hepatitis (AIH...

In a significant stride towards addressing unmet medical needs in immune-mediated disorders, Kezar Life Sciences Inc. (Nasdaq: KZR) has unveiled promising topline results from its PORTOLA Phase 2a clinical trial, evalua...

FDA Places Clinical Hold on Kezar Life Sciences Zetomipzomib IND for Lupus Nephritis South San Francisco-based biotechnology firm, Kezar Life Sciences, Inc. (Nasdaq: KZR), announced a significant regulatory development...

: Recent developments from Kezar Life Sciences have surfaced significant occurrences regarding its pipeline and strategic financial maneuvers. This article assesses the implications of the FDA s clinical hold on the zet...

In the ever-evolving landscape of clinical trials, some moments shine bright with promise, while others echo with caution. Kezar Life Sciences, a prominent player in the biotechnology arena, recently announced a pivotal...

Granting Leverage: Kezar Life Sciences Fosters Growth with Strategic Inducement Grant Kezar Life Sciences, Inc.: Driving Innovation in Immune-Mediated Diseases and Cancer Therapeutics Kezar Life Sciences, Inc. (Nasdaq:...

Kezar Life Sciences: Strategic Inducement Grant and Q1 2024 Financial Highlights Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company specializing in innovative small molecule therapeutics to...

Kezar Life Sciences, Inc. (Nasdaq: KZR), a prominent clinical-stage biotechnology company, has once again demonstrated its commitment to fostering innovation and addressing significant unmet medical needs. By developing...

Kezar Life Sciences Excels in First Quarter 2024 with Groundbreaking Advances in Immunology and OncologySOUTH SAN FRANCISCO, Calif. - Kezar Life Sciences, Inc. (Nasdaq: KZR), a pioneering clinical-stage biotechnology co...

Kezar Life Sciences Reports Positive Financial Results and Promising Advances in Immune-Mediated Disease and Cancer TherapiesSOUTH SAN FRANCISCO, Calif. - Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotec...